Loading...
Elizete De Oliveira Da Silva — Nivolumab Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #9 buyer for Nivolumab · $11.8K import value · 4 shipments · BRAZIL · DGFT Verified
Elizete De Oliveira Da Silva is the #9 importer of Nivolumab from India with $11.8K in import value and 4 verified shipments. Elizete De Oliveira Da Silva holds a 0.5% market share in Nivolumab imports based in BRAZIL.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LTD | $577.4K | 15 | 5 |
| CORSANTRUM TECHNOLOGY | $115.1K | 22 | 1 |
| VAMA LIFECARE PRIVATE LIMITED | $72.9K | 7 | 1 |
| MODERN DRUG HOUSE | $28.7K | 15 | 1 |
| SPECIALITY MEDICINES LIMITED | $28.6K | 10 | 1 |
| RBN MEDITECH PRIVATE LIMITED | $28.4K | 12 | 1 |
| VEA IMPEX I PRIVATE LIMITED | $27.9K | 4 | 3 |
| SPECIALITY MEDICINES PRIVATE LIMITED | $27.8K | 6 | 1 |
| MEDIX | $27.0K | 5 | 1 |
| NU HOSPITALS PRIVATE LIMITED | $12.0K | 5 | 1 |
India's top Nivolumab suppliers include DR.REDDY'S LABORATORIES LTD, CORSANTRUM TECHNOLOGY, VAMA LIFECARE PRIVATE LIMITED. These companies represent the primary source of Nivolumab exports from India, serving buyers like Elizete De Oliveira Da Silva in BRAZIL and other global markets.
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | INDIRA GANDHI MEMORIAL HOSPITAL | MALDIVES | $12.0K | 5 | $2.4K |
| 8 | FRANCISCO EUDES DA SILVA | BRAZIL | $11.8K | 2 | $5.9K |
| 9 | ELIZETE DE OLIVEIRA DA SILVA ★ | BRAZIL | $11.8K | 4 | $2.9K |
| 10 | INVOICE RAISED TO SEYCHELLES | SEYCHELLES | $11.8K | 2 | $5.9K |
What Elizete De Oliveira Da Silva and other importers must comply with to import Nivolumab from India
Brazilian Health Regulatory Agency (ANVISA)
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
India exported $733.9K worth of Nivolumab through 144 shipments from 23 suppliers to 13 countries, serving 47 buyers globally. Elizete De Oliveira Da Silva imports $11.8K of this total, accounting for 0.5% of India's Nivolumab exports with 4 shipments from BRAZIL.
Elizete De Oliveira Da Silva's average Nivolumab order value is $2.9K per consignment, based on 4 shipments totaling $11.8K. Elizete De Oliveira Da Silva is based in BRAZIL and ranks #9 among all Nivolumab importers from India by value.
Top Indian Nivolumab suppliers include DR.REDDY'S LABORATORIES LTD ($577.4K), CORSANTRUM TECHNOLOGY ($115.1K), VAMA LIFECARE PRIVATE LIMITED ($72.9K), MODERN DRUG HOUSE ($28.7K), SPECIALITY MEDICINES LIMITED ($28.6K). These companies represent the primary source of Nivolumab exports from India.
Elizete De Oliveira Da Silva ranks #9 among 47 Nivolumab importers from India with a 0.5% market share. The top 3 importers are COREX LLC ($400.0K), ALMAC PHARMACEUTICAL SERVICES PTE LIMITED ($100.0K), AS PER INVOICE ($72.9K). Elizete De Oliveira Da Silva processed 4 shipments from BRAZIL.
Latest developments and market context
Detailed market intelligence for Nivolumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Elizete De Oliveira Da Silva's Nivolumab imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| 11 |
| RINEA IVETE ROOS BOER |
| BRAZIL |
| $11.2K |
| 2 |
| $5.6K |
Elizete De Oliveira Da Silva ranks #9 among 47 Nivolumab importers from India. Average shipment value of $2.9K compared to the market average of $15.6K. The closest competitors by value are INDIRA GANDHI MEMORIAL HOSPITAL and FRANCISCO EUDES DA SILVA.
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 13+ countries, 47+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Elizete De Oliveira Da Silva.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nivolumab. For current order-level data, contact TransData Nexus.